Publication:
lnhibited differentiation of Langerhans cells in the rat epidermis upon systemic treatment with cyclosporin A

relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Borghi-Cirri, M.B. ; Riccardi-Arbi, R. ; Bacci, S. ; Mori, M. ; Pimpinelli, N. ; Romagnoli, P. ; Filipponi, F.
item.page.secondaryauthor
item.page.director
Publisher
Murcia : F. Hernández
publication.page.editor
publication.page.department
DOI
item.page.type
info:eu-repo/semantics/article
Description
Abstract
The immunosuppressant drug cyclosporin A (CsA) is known to cause reduction in number, DNA synthesis and function of Langerhans cells (LC). Since also the differentiation of LC is known to be hampered in conditions of acquired immunodeficiency not due to drugs, we investigated whether this occurs with CsA. Rats were injected subcutaneously with CsA (5, 10 and 50 mg.kg-l.d-l) for three weeks; the skin was analyzed by Ia immunohistochemistry and by electron microscopy. Epidermal immunolabeled cells were 1553.5 (mean I SEM) per 100 basa1 keratinocytes in untreated controls and 8.7511.3, 4.7551.0 and 1.751.2 upon increasing doses of CsA (pe0.01). By electron microscopy, monocytoid cells with deep invaginations of the plasma membrane and roundish LC poor in Birbeck granules appeared in the epidermis upon treatment. The results suggest that CsA inhibits the differentiation of LC precursors in the epidermis and that this can in part explain the selective increase in the risk of skin vira1 disease and cancer in chronically treated patients.
publication.page.subject
Citation
item.page.embargo